Example: Heart Attack

Clinical Trials on Dengue

Total 206 results

NCT03612609

Completed

Pilot Study to Detect DENGUE Virus in Sperm

Conditions: Dengue
NCT04298138

Not yet recruiting

Dengue 3 Human Infection Model (DENV-3)

Conditions: Dengue
NCT04133987

Recruiting

Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwan

Conditions: Dengue
NCT03869060

Completed

Expansion of a Dengue-1 Live Virus Human Challenge

Conditions: Dengue
NCT02684383

Completed

Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine

Conditions: Dengue
NCT02879266

Completed

Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age

Conditions: Dengue
NCT02372175

Completed

Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain

Conditions: Dengue
NCT02873260

Completed

Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30

Conditions: Dengue
NCT02678455

Completed

Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh

Conditions: Dengue
NCT02239614

Completed

TDENV PIV and LAV Dengue Prime-boost Strategy

Conditions: Dengue
NCT02433652

Completed

Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2

Conditions: Dengue
NCT02450838

Completed

Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)

Conditions: Dengue
NCT01563640

Terminated

Insecticidal School Uniforms for Dengue Prevention in Thailand

Conditions: Dengue
NCT02606019

Unknown status

The Use of Biomarkers in Predicting Dengue Outcome

Conditions: Dengue
NCT03799237

Unknown status

Combating Dengue With Innovative, Paradigm-shift-Strategies: Early Dengue Surveillance in Adult Aedes Mosquitoes

Conditions: Dengue
NCT02570152

Completed

A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia

Conditions: Dengue
NCT01110551

Completed

Tetravalent Chimeric Dengue Vaccine Trial

Conditions: Dengue
NCT03960385

Completed

Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil

Conditions: Dengue
NCT04582474

Recruiting

Demonstration of an Electronic Clinical Decision Support Module for Dengue in Burkina Faso

Conditions: Dengue
NCT02766088

Terminated

This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia

Conditions: Dengue
NCT01696422

Unknown status

Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine

Conditions: Dengue
NCT04063774

Completed

Clinical Trial of Diagnostic Tests and Clinical Algorithms for Dengue in Febrile Subjects in Endemic Areas in Colombia

Conditions: Dengue
NCT01502735

Completed

Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease

Conditions: Dengue Fever
NCT04597437

Not yet recruiting

Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)

Conditions: Dengue Fever
NCT00377754

Unknown status

Prospective Study of Infant Dengue

Conditions: Dengue